Easywell Biomedicals (Taiwan) Probability of Future Stock Price Finishing Under 39.68
| 1799 Stock | TWD 66.50 2.10 3.06% |
Easywell |
Easywell Biomedicals Target Price Odds to finish below 39.68
The tendency of Easywell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to NT$ 39.68 or more in 90 days |
| 66.50 | 90 days | 39.68 | nearly 4.36 |
Based on a normal probability distribution, the odds of Easywell Biomedicals to drop to NT$ 39.68 or more in 90 days from now is nearly 4.36 (This Easywell Biomedicals probability density function shows the probability of Easywell Stock to fall within a particular range of prices over 90 days) . Probability of Easywell Biomedicals price to stay between NT$ 39.68 and its current price of NT$66.5 at the end of the 90-day period is about 7.21 .
Assuming the 90 days trading horizon Easywell Biomedicals has a beta of 0.26. This suggests as returns on the market go up, Easywell Biomedicals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Easywell Biomedicals will be expected to be much smaller as well. Additionally Easywell Biomedicals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Easywell Biomedicals Price Density |
| Price |
Predictive Modules for Easywell Biomedicals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Easywell Biomedicals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Easywell Biomedicals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Easywell Biomedicals is not an exception. The market had few large corrections towards the Easywell Biomedicals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Easywell Biomedicals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Easywell Biomedicals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.74 | |
β | Beta against Dow Jones | 0.26 | |
σ | Overall volatility | 52.31 | |
Ir | Information ratio | -0.38 |
Easywell Biomedicals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Easywell Biomedicals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Easywell Biomedicals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Easywell Biomedicals generated a negative expected return over the last 90 days | |
| Easywell Biomedicals has high historical volatility and very poor performance | |
| Net Loss for the year was (183.52 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Easywell Biomedicals has accumulated about 399.51 M in cash with (102.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.49. |
Easywell Biomedicals Technical Analysis
Easywell Biomedicals' future price can be derived by breaking down and analyzing its technical indicators over time. Easywell Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Easywell Biomedicals. In general, you should focus on analyzing Easywell Stock price patterns and their correlations with different microeconomic environments and drivers.
Easywell Biomedicals Predictive Forecast Models
Easywell Biomedicals' time-series forecasting models is one of many Easywell Biomedicals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Easywell Biomedicals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Easywell Biomedicals
Checking the ongoing alerts about Easywell Biomedicals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Easywell Biomedicals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Easywell Biomedicals generated a negative expected return over the last 90 days | |
| Easywell Biomedicals has high historical volatility and very poor performance | |
| Net Loss for the year was (183.52 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Easywell Biomedicals has accumulated about 399.51 M in cash with (102.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.49. |
Additional Tools for Easywell Stock Analysis
When running Easywell Biomedicals' price analysis, check to measure Easywell Biomedicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easywell Biomedicals is operating at the current time. Most of Easywell Biomedicals' value examination focuses on studying past and present price action to predict the probability of Easywell Biomedicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easywell Biomedicals' price. Additionally, you may evaluate how the addition of Easywell Biomedicals to your portfolios can decrease your overall portfolio volatility.